GABA 300-EZS

Generic: GABAPENTIN

Manufacturer: Aci Healthcare Usa, Inc.

Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]Corticosteroid [EPC]Proton Pump Inhibitor [EPC]Provitamin D2 Compound [EPC]
281,518
Total Reports
105,586
Serious Reports
28,048
Death Reports
30
Reported Reactions
Death Report Ratio: High (9.96%)

Patient Demographics

Male
92,201
Female
166,083

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for GABA 300-EZS.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 22,671
7.4%
2 FATIGUE 20,222
6.6%
3 NAUSEA 17,594
5.7%
4 OFF LABEL USE 16,484
5.4%
5 PAIN 16,154
5.3%
6 DIARRHOEA 14,569
4.7%
7 HEADACHE 13,837
4.5%
8 DIZZINESS 12,428
4.0%
9 FALL 12,017
3.9%
10 DYSPNOEA 10,977
3.6%
11 VOMITING 9,336
3.0%
12 DEATH 9,314
3.0%
13 ARTHRALGIA 9,179
3.0%
14 ASTHENIA 9,125
3.0%
15 PAIN IN EXTREMITY 8,962
2.9%
16 MALAISE 8,378
2.7%
17 PNEUMONIA 8,114
2.6%
18 ANXIETY 7,479
2.4%
19 SOMNOLENCE 7,230
2.4%
20 RASH 7,095
2.3%
21 BACK PAIN 7,086
2.3%
22 DEPRESSION 7,064
2.3%
23 INSOMNIA 6,923
2.3%
24 DRUG HYPERSENSITIVITY 6,859
2.2%
25 WEIGHT DECREASED 6,735
2.2%
26 CONDITION AGGRAVATED 6,608
2.1%
27 GAIT DISTURBANCE 6,356
2.1%
28 CONSTIPATION 6,353
2.1%
29 FEELING ABNORMAL 6,276
2.0%
30 TOXICITY TO VARIOUS AGENTS 6,086
2.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.